CCR5 and Acute hepatitis: In a model of Concanavalin A-induced acute hepatitis, the treatment of CCR5-/- mice with a monoclonal anti-CCL5 antibody led to markedly reduced hepatocyte damage [45] and a significant reduction in NK cells in the liver parenchyma [16].